Listed Price₹900.05
Listing Gain+21.46%
Price Band₹705 - ₹741
Lot Size20 shares
Min Bid₹14,820
Subscription26.13x
Listed Market Snapshot
₹900.05Listed price from market data
+21.46%listing gain
Issue Amount
₹1,551 Cr
Listed Price
₹900.05
Current Price
₹1315.1
Registrar
Link Intime India Private Limited
Timeline•Book Built Issue IPO
Open04 Aug 2023
Close08 Aug 2023
Allotment14 Aug 2023
Listing18 Aug 2023
Quota Reservation Portions
QIBPortion: 1,04,57,825 shares
49.98%Nii (hni)Portion: 31,37,348 shares
14.99%RetailPortion: 73,20,479 shares
34.98%EmployeePortion: 10,000 shares
0.05%Minimum Application Bracket Matrix
Retail1 lots / 20 shares
₹14,820sHNI14 lots / 280 shares
₹2,07,480bHNI68 lots / 1,360 shares
₹10,07,760About the Company
Incorporated in 1984, Concord Biotech Limited is an India-based biopharmaceutical company and a leading global developer and manufacturer of fermentation-based APIs, specializing in immunosuppressants and oncology. The company has a strong global presence, supplying products to over 70 countries including the USA, India, Europe, and Japan. Concord Biotech manufactures Active Pharmaceutical Ingredients (APIs) through fermentation and semi-synthetic processes, along with finished formulations. Starting with a single product, the company has expanded to offer a broad spectrum of biopharma solutions, establishing itself as a key player in the global API market.
Company Promoters
Mr. Sudhir VaidMr. Ankur Vaid
Lead Managers
Registrar
Link Intime India Private Limited